Gene Variants and Metabolic Syndrome in Turkey
Author Information
Author(s): Jabbarli Marjan, Senkal Naci, Tuncel Fatima Ceren, Oyaci Yasemin, Guzel Dirim Merve, Kose Murat, Pehlivan Sacide, Medetalibeyoglu Alpay
Primary Institution: Istanbul University
Hypothesis
The study evaluates the effects of LEP and LEPR gene variants on clinical findings and risk of developing metabolic syndrome in the Turkish population.
Conclusion
The LEP rs7799039 and LEPR rs1137101 variants may be associated with the risk of developing metabolic syndrome and its clinical features.
Supporting Evidence
- LEP rs7799039 GA and AA genotypes were more frequent in patients with metabolic syndrome compared to controls.
- Individuals with LEP rs7799039 GA and AA genotypes had higher triglyceride levels.
- Patients with the AG-GG genotype of LEPR rs1137101 had lower mean hemoglobin levels.
Takeaway
This study looked at how certain genes might affect the chances of getting metabolic syndrome, a health problem that can lead to serious diseases.
Methodology
320 patients were genotyped for LEP rs7799039 and LEPR rs1137101 variants using blood samples and PCR methods.
Limitations
The sample size of certain subgroups was limited, and only two gene variants were studied.
Participant Demographics
150 patients with metabolic syndrome (92 females, 58 males) and 170 healthy controls (87 females, 83 males).
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website